- Home
- CIM vs INVA Comparison
CIM vs INVA Comparison
Compare CIM & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIM
- INVA
- Stock Information
- Founded
- CIM 2007
- INVA 1996
- Country
- CIM United States
- INVA United States
- Employees
- CIM N/A
- INVA N/A
- Industry
- CIM Real Estate Investment Trusts
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- CIM Real Estate
- INVA Health Care
- Exchange
- CIM Nasdaq
- INVA Nasdaq
- Market Cap
- CIM 1.1B
- INVA 1.2B
- IPO Year
- CIM 2007
- INVA 2004
- Fundamental
- Price
- CIM $13.17
- INVA $19.57
- Analyst Decision
- CIM Buy
- INVA Buy
- Analyst Count
- CIM 3
- INVA 1
- Target Price
- CIM $15.50
- INVA $55.00
- AVG Volume (30 Days)
- CIM 542.4K
- INVA 637.7K
- Earning Date
- CIM 05-08-2025
- INVA 05-07-2025
- Dividend Yield
- CIM 11.23%
- INVA N/A
- EPS Growth
- CIM N/A
- INVA N/A
- EPS
- CIM 1.52
- INVA N/A
- Revenue
- CIM $326,755,000.00
- INVA $369,844,000.00
- Revenue This Year
- CIM $18.94
- INVA $3.75
- Revenue Next Year
- CIM $3.05
- INVA $12.62
- P/E Ratio
- CIM $8.68
- INVA N/A
- Revenue Growth
- CIM 11.90
- INVA 18.70
- 52 Week Low
- CIM $9.85
- INVA $15.32
- 52 Week High
- CIM $16.89
- INVA $21.28
- Technical
- Relative Strength Index (RSI)
- CIM 54.16
- INVA 71.81
- Support Level
- CIM $12.77
- INVA $18.59
- Resistance Level
- CIM $13.37
- INVA $19.08
- Average True Range (ATR)
- CIM 0.28
- INVA 0.39
- MACD
- CIM -0.04
- INVA 0.08
- Stochastic Oscillator
- CIM 28.83
- INVA 94.89
About CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.